Status:
UNKNOWN
Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients
Lead Sponsor:
KU Leuven
Conditions:
Neurofibromatosis Type 1
Eligibility:
All Genders
Brief Summary
Neurofibromatosis type 1 (NF1) is a frequent, autosomal dominant disorder caused by heterozygous mutations (intragenic or microdeletion) of the NF1 tumor suppressor gene (chr.17q11.2). One of the clin...
Detailed Description
Introduction Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder occuring in 1 out of 3500 living newborns. The disease is caused by heterozygous mutations of the NF1 gene, located on chr...
Eligibility Criteria
Inclusion
- NF1 patient
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01218139
Start Date
September 1 2007
End Date
December 1 2010
Last Update
October 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KUL
Leuven, Vlaams-Brabant, Belgium, 3000